Medicus Pharma MDCX
NASDAQ MDCX
$2.70 -0.02 (-0.74%)
As of: Oct 21, 2026 · 1:53 PM EDT

Medicus Pharma (MDCX) Debt Ratio (2025 - 2026)

Updated

Medicus Pharma's (MDCX) Debt Ratio came in at 0.79 for Q2 2026, up 101.2% from 0.39 a year earlier.

Analysis

Medicus Pharma (MDCX) Debt Ratio (2025 - 2026) Analysis & Trends

For FY2025, Medicus Pharma's Debt Ratio stood at 0.52.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,134.24 Bn 1,102.83 Bn 19.71 Bn 0.39
2 Johnson & Johnson 616.05 Bn 534.58 Bn 17.26 Bn 0.24
3 AbbVie 500.90 Bn 474.01 Bn 12.70 Bn 0.52
4 Merck 367.17 Bn 321.54 Bn 12.21 Bn 0.42
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 0.08
6 Astrazeneca 261.35 Bn 235.03 Bn 12.86 Bn 0.28
7 Amgen 235.77 Bn 191.17 Bn 7.24 Bn 0.60
8 Gilead Sciences 190.70 Bn 164.90 Bn 6.22 Bn 0.53
9 Pfizer 169.35 Bn 115.99 Bn 10.94 Bn 0.31
10 Medicus Pharma 2.96 Mn -39.25 Mn - 0.79
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.79
Dec 31, 2025 0.52
Sep 30, 2025 0.68
Jun 30, 2025 0.39
API Access

Medicus Pharma Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=MDCX&period=max&api_key=YOUR_API_KEY